Biotechnology Developer Offers an Attractive Investment Opportunity

LentiKat's (Czech Republic) has decided to spin-out the WWT segment on its own and this is a rare investment opportunity for all potential candidates.

LentiKat’s develops, manufactures and distributes Lentikats Biotechnology - a unique patented method that uses a porous carrier made of polyvinyl alcohol (PVA) for the immobilisation of enzymes or whole cells that can be applied in a number of industries, including wastewater treatment. Immobilised microorganisms can be successfully used for the removal of nitrogen pollution and biodegradable organic compounds from municipal and industrial wastewaters (including those with high and fluctuating concentrations) and for selective biodegradations. The porous carrier allows diffusion of media (wastewater) to the entrapped organisms which perform the bioconversions (Figure 1).

Lentikats Biotechnology offers an elegant, stable and tailor-made solution with proven full scale (Figure 2) and pilot-plant WWT applications. Lentikats Biotechnology advantages compared to other similar technologies (MBBR) are:

·      Rapid start up and high biological activity,

·      Smaller foot print,

·      Low operational costs,

·      Easy control of process operation,

·      Stability in extreme concentrations,

·      Ability to respond even highly fluctuating concentrations.

Wastewater treatment segment has great potential for future development in field of immobilisation of deammonification or nitritation bacteria, and removal of specific pollutants and micropollutants. Please find more information about the investment opportunity here.